Cardiac safety of chronic inhibition of the myostatin–activin pathway with bimagrumab in healthy older adults

Journal:

Journal of Clinical Endocrinology & Metabolism

Published:

2026-03-25

DOI:

10.1210/clinem/dgag091

Affiliations:

8

Authors:

10

Go to article

Institutions	Authors	Share
Novartis Biomedical Research, United States of America (USA)	4.000000	0.40
Novartis Biomedical Research, Switzerland	2.000000	0.20
Novartis Health Care Pvt. Ltd., India	1.000000	0.10
Novartis Pharmaceuticals Corporation, United States of America (USA)	1.000000	0.10
Leiden University Medical Center (LUMC), Netherlands	1.000000	0.10
Baptist Health Miami Cardiac and Vascular Institute, United States of America (USA)	0.500000	0.05
Florida International University (FIU), United States of America (USA)	0.500000	0.05

Interested in Animal Production?